These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Vachtenheim J, Ondrusová L, Borovanský J. Biochem Biophys Res Commun; 2010 Feb 12; 392(3):454-9. PubMed ID: 20083088 [Abstract] [Full Text] [Related]
4. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma. Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD. Pigment Cell Melanoma Res; 2010 Feb 12; 23(1):93-102. PubMed ID: 19895547 [Abstract] [Full Text] [Related]
5. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R. Oncogene; 2012 May 10; 31(19):2461-70. PubMed ID: 21996743 [Abstract] [Full Text] [Related]
6. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells. Sestáková B, Ondrusová L, Vachtenheim J. Pigment Cell Melanoma Res; 2010 Apr 10; 23(2):238-51. PubMed ID: 20067556 [Abstract] [Full Text] [Related]
7. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D. Cancer Res; 2008 May 01; 68(9):3124-32. PubMed ID: 18451137 [Abstract] [Full Text] [Related]
8. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells. Laurette P, Strub T, Koludrovic D, Keime C, Le Gras S, Seberg H, Van Otterloo E, Imrichova H, Siddaway R, Aerts S, Cornell RA, Mengus G, Davidson I. Elife; 2015 Mar 24; 4():. PubMed ID: 25803486 [Abstract] [Full Text] [Related]
9. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1. Fang D, Setaluri V. Biochem Biophys Res Commun; 1999 Mar 24; 256(3):657-63. PubMed ID: 10080955 [Abstract] [Full Text] [Related]
10. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Kim A, Yang Y, Lee MS, Yoo YD, Lee HG, Lim JS. Pigment Cell Melanoma Res; 2008 Dec 24; 21(6):653-64. PubMed ID: 19067970 [Abstract] [Full Text] [Related]
11. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Cheli Y, Giuliano S, Botton T, Rocchi S, Hofman V, Hofman P, Bahadoran P, Bertolotto C, Ballotti R. Oncogene; 2011 May 19; 30(20):2307-18. PubMed ID: 21278797 [Abstract] [Full Text] [Related]
12. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor]. Denat L, Larue L. Bull Cancer; 2007 Jan 19; 94(1):81-92. PubMed ID: 17237008 [Abstract] [Full Text] [Related]
13. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Goodall J, Carreira S, Denat L, Kobi D, Davidson I, Nuciforo P, Sturm RA, Larue L, Goding CR. Cancer Res; 2008 Oct 01; 68(19):7788-94. PubMed ID: 18829533 [Abstract] [Full Text] [Related]
14. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF. Anghel SI, Correa-Rocha R, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Lévy F, Delorenzi M, Piguet V. Pigment Cell Melanoma Res; 2012 Jul 01; 25(4):482-7. PubMed ID: 22594792 [Abstract] [Full Text] [Related]
15. Novel MITF targets identified using a two-step DNA microarray strategy. Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E. Pigment Cell Melanoma Res; 2008 Dec 01; 21(6):665-76. PubMed ID: 19067971 [Abstract] [Full Text] [Related]
16. MITF pathway mutations in melanoma. Yokoyama S, Salma N, Fisher DE. Pigment Cell Melanoma Res; 2009 Aug 01; 22(4):376-7. PubMed ID: 19558635 [No Abstract] [Full Text] [Related]
17. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, Testori A, Larue L, Goding CR. Genes Dev; 2006 Dec 15; 20(24):3426-39. PubMed ID: 17182868 [Abstract] [Full Text] [Related]
18. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, Virolle T, Barbry P, Pouysségur J, Ponzio G, Ballotti R. J Cell Biol; 2005 Jul 04; 170(1):49-59. PubMed ID: 15983061 [Abstract] [Full Text] [Related]
19. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, Mauviel A. Pigment Cell Melanoma Res; 2011 Oct 04; 24(5):932-43. PubMed ID: 21801332 [Abstract] [Full Text] [Related]
20. Microphthalmia transcription factor: a specific marker for malignant melanoma. Vachtenheim J, Borovanský J. Prague Med Rep; 2004 Oct 04; 105(3):318-24. PubMed ID: 15782558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]